Concepedia

Lucrezia Camicia

LC

6

Publications

137

Citations

6

H-Index

2018

Active since

Affiliations

Centro di Riferimento Oncologico(Current)

Sapienza University of Rome

Istituti di Ricovero e Cura a Carattere Scientifico

Alder Hey Children's NHS Foundation Trust

Lucrezia Camicia is an author at Centro di Riferimento Oncologico specializing in tumor biology, cancer therapeutics, and oncology.

ORCID

Top concepts

Publications per year

2018–2022

6

Publications

6

PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines

Simona Camero, Simona Ceccarelli, Francesca De Felice et al. · Journal of Cancer Research and Clinical Oncology · 2018 · 35 citations · Full text

Colorectal cancer development is affected by the ECM molecule EMILIN-2 hinging on macrophage polarization via the TLR-4/MyD88 pathway

Eva Andreuzzi, Albina Fejza, Maurizio Polano et al. · Journal of Experimental & Clinical Cancer Research · 2022 · 30 citations · Full text

BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cells

Simona Camero, Lucrezia Camicia, Francesco Marampon et al. · Cancer Letters · 2020 · 24 citations · Full text

, , +10

The Efficacy of Anti-PD-L1 Treatment in Melanoma Is Associated with the Expression of the ECM Molecule EMILIN2

Albina Fejza, Maurizio Polano, Lucrezia Camicia et al. · International Journal of Molecular Sciences · 2021 · 18 citations · Full text

OTX015 Epi-Drug Exerts Antitumor Effects in Ovarian Cancer Cells by Blocking GNL3-Mediated Radioresistance Mechanisms: Cellular, Molecular and Computational Evidence

Francesca Megiorni, Simona Camero, Paola Pontecorvi et al. · Cancers · 2021 · 17 citations · Full text

, , +17

Rows per page

1–5 of 6